Zhejiang Medicine Co., Ltd.

Overview

Zhejiang Medicine Co., Ltd. is a leading pharmaceutical company based in China, specializing in the development, manufacture, and distribution of a wide range of medicines, including active pharmaceutical ingredients and finished dosage forms. The company is committed to advancing healthcare through innovative research and development.

Therapeutic areas

API / Drug Master Files

Zhejiang Medicine Co., Ltd. holds 14 active (14 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• RIFAXIMINActive2023-11-29
• ETHYL ICOSAPENTATEActive2023-10-30
• ETHYL ICOSAPENTATE 70Active2021-12-10
• MINOCYCLINE HYDROCHLORIDEActive2018-05-14
• LEVOFLOXACINActive2017-07-19
• CRUDE CARBIDOPAActive2013-01-07
• DAPTOMYCINActive2013-01-07
• GABAPENTINActive2007-08-20
• METHYLDOPAActive2007-05-15
• CALCIUM POLYCARBOPHILActive2007-01-18
• CARBIDOPAActive2006-10-16
• VANCOMYCIN HYDROCHLORIDE USP (NON-STERILE API)Active2005-10-19
• MIGLITOLActive2005-01-22
• ETODOLACActive2003-08-25

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Zhejiang Medicine Co., Ltd. in our records. PharmaTek screens the full directory against live FDA enforcement data.